Definitive Contract 75F40121C00088
Award Date
9/20/21
Potential Completion Date
6/29/24
Potential Value
$222K
Federal Agency
Food and Drug Administration
Ultimate Awardee
University System Of Maryland
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $750,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, College Park (UMD) to support the agency's FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research efforts. The contract has a period of performance through March 30, 2024 and utilizes cost-reimbursement pricing with no fee. UMD is providing research, analysis, and other professional services related to the COVID-19 pandemic response. This award...
This federal contract was awarded by the Food and Drug Administration (FDA) to the University of Maryland, with a ceiling value of $2,701,214.75. The contract, titled "Genome Sequencing of Diverse Pathogens," is a definitive, firm-fixed-price contract for research and data management services related to genome sequencing. The University of Maryland is the prime contractor, and the contract does not have a set-aside designation. The contract is associated with the University System of...
This federal contract award, valued at $669,734.24, was issued by the Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) to provide NONDESTRUCTIVE ANALYTICS FOR VACCINES. The contract is a definitive, firm fixed-price agreement, with a period of performance through March 29, 2024. UMB, the prime contractor, is a major public research university and the founding campus of the University System of Maryland (USM). The contract does not have a set-aside designation....
This is a $89,364.16 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Maryland, College Park. The contract is for the STEM-designated Executive Master's in Business Administration (EMBA) for Executive Staff Program. The contract has an ultimate completion date of October 31, 2024. There is no set-aside designation for this award. The University of Maryland, College Park is the prime contractor and will be providing executive-level...
The University of Maryland, College Park was awarded a $1.2 million cost-no-fee definitive contract by the Centers for Disease Control and Prevention (CDC) to support COVID-19 BAA Topic 2 efforts in Maryland. Under the contract, the prime contractor and subcontractor University of Maryland, Baltimore will conduct real-world tests of face coverings as source control for COVID-19 transmission. The period of performance is from August 2020 through September 2021, with work taking place in...
The University of Maryland, Baltimore has been awarded a federal contract by the Food and Drug Administration to generate highly curated whole genome sequences for bacterial pathogens from the FDA-CDC Antimicrobial Resistance Isolate Bank. The $199,985.00 definitive, firm fixed-price contract does not have a set-aside designation. The University of Maryland, Baltimore is the prime contractor and is a major public research university that frequently receives federal funding through contracts...
This federal contract award, valued at $99,999.99, was granted to the University of Maryland, College Park by the Shared Services Center, a civilian agency. The award is for a research grant related to the COVID-19 pandemic, with a performance period ending on December 10, 2021. The University of Maryland, College Park is a state-controlled institution of higher learning that has previously received federal contract and grant awards from agencies like the Department of Defense, Department of...
The Office of the Secretary of Defense awarded a $1.67 million cost-plus-fixed-fee delivery order contract to the University of Maryland, College Park under its COVID Response Research Support Services requirement. The prime contractor will provide testing of different messages for COVID-19 vaccine intentions through June 2022. A subcontract of unspecified value was also awarded to Cornell University to support this purpose. The place of performance will be College Park, Maryland. This...
This is a $134,998.17 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to the University of Maryland, College Park (UMD) to conduct a collaborative study with Walter Reed Army Medical Center (WRAMC) on the use of non-contact infrared thermometers (NCITs) and thermal cameras for fever screening. The contract does not have a set-aside designation. As a state-controlled institution of higher learning, UMD has a history of receiving prime federal contracts and grants...
This federal contract award is for UNIVERSITY OF MARYLAND TUITION AND EDUCATION FEES, provided by the University of Maryland, College Park to the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is a firm fixed price purchase order with a potential value of $10,320.50, and has a completion date of January 27, 2020. The contract does not have a set-aside designation. The University of Maryland, College...